Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Executive VP and CFO of H.B. Fuller, John J. Corkrean, filed a Form 4 detailing changes in beneficial ownership, including the acquisition of phantom units and adjustments to stock options and restricted stock units.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 with the SEC.
- The report details changes in his beneficial ownership of H.B. Fuller securities.
- The transactions include the acquisition of 166.12 phantom units on February 28, 2025, at a price of $56.74.
- Corkrean directly owns 52,196 shares of common stock.
- He also holds various employee stock options with different exercise prices and expiration dates, as well as restricted stock units.
- The report includes information on vesting schedules for options and restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, restricted stock units, and other incentives.
- The vesting schedules and exercise prices of the stock options are typical for executive compensation plans.
- Companies like 3M, Dow, and Sherwin-Williams also utilize similar compensation structures for their executives.
Stakeholder Impact
- Shareholders can use this information to understand the alignment of management's interests with their own.
- The filing provides transparency into the executive's holdings and transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of employee stock option grant with an exercise price of $43.48, 100% vested, expiring on 05/17/2026. |
| 01/26/2018 | Date of employee stock option grant with an exercise price of $50.1, 100% vested, expiring on 01/26/2027. |
| 01/25/2019 | Date of employee stock option grant with an exercise price of $53.57, 100% vested, expiring on 01/25/2028. |
| 01/24/2020 | Date of employee stock option grant with an exercise price of $45.05, 100% vested, expiring on 01/24/2029. |
| 01/24/2021 | Date of employee stock option grant with an exercise price of $48.35, 100% vested, expiring on 01/24/2030. |
| 01/27/2022 | Date of employee stock option grant with an exercise price of $51.89, 100% vested, expiring on 01/27/2031. |
| 01/24/2023 | Date of employee stock option grant with an exercise price of $72.94, vesting in three annual installments, expiring on 01/24/2032. |
| 01/24/2024 | Date of employee stock option grant with an exercise price of $68.17, vesting in three annual installments, expiring on 01/24/2033. |
| 01/24/2024 | Date of restricted stock unit grant, vesting in three annual installments, expiring on 01/24/2026. |
| 01/26/2025 | Date of employee stock option grant with an exercise price of $77.72, vesting in three annual installments, expiring on 01/26/2034. |
| 01/26/2025 | Date of restricted stock unit grant, vesting in three annual installments, expiring on 01/26/2027. |
| 01/27/2026 | Date of employee stock option grant with an exercise price of $64.28, vesting in three annual installments, expiring on 01/27/2035. |
| 01/27/2026 | Date of restricted stock unit grant, vesting in three annual installments, expiring on 01/27/2028. |
| 02/28/2025 | Date of transaction: Acquisition of 166.12 phantom units. |
| 03/03/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.